GAO Prescribes Ways to Prevent Drug Adulteration
By Mari Serebrov
Tuesday, November 29, 2011
WASHINGTON When it comes to the economic adulteration of drugs, an ounce of prevention could end up costing the biopharma industry what it considers confidential information.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.